NAFDAC warns of fake Avastin cancer drug vials in Nigeria
NAFDAC has identified counterfeit Avastin 400mg vials circulating in Nigeria, posing serious health risks to cancer patients. The falsified medicine, used to treat glioblastoma, was discovered through complaints from an oncologist about authenticity concerns. Investigation revealed multiple discrepancies including non-existent batch numbers (K1830T71, H0375B01), incorrect packaging text, spelling errors, and mismatched serial numbers. These findings confirm the products are counterfeit and unsafe. The fake vials list Roche Diagnostics GmbH as manufacturer but contain no valid GTIN or traceable manufacturing data. Patients should only obtain medicines from licensed suppliers and verify authenticity before use. NAFDAC is intensifying surveillance nationwide to remove these products from circulation.